Ascendis Pharma Reports Fourth Quarter and Full Year 2024 Financial Results
Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million– Following ...
MM&M18h
How new direct-to-consumer platforms are changing pharma’s relationships with patients
New DTC platforms like LillyDirect and PfizerForAll are triggering a paradigm shift in how pharma companies connect with patients.
EPIX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of ESSA Pharma Inc. to Contact the Firm Today!
NEW YORK, NY / ACCESS Newswire / February 12, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...
MM&M2d
Pharma brands are struggling to keep the attention of digitally savvy HCPs
It’s critical to understand what a digitally savvy HCP is in 2025 and what’s impeding pharma's communications with this ...
Pharma Companies Turn to AI to Speed Up Drug Development, But Hit Hurdles
Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...